Comparative effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) vaccines in preventing COVID-19 hospitalizations among adults without immunocompromising … WH Self MMWR. Morbidity and mortality weekly report 70, 2021 | 499 | 2021 |
Serologic testing of US blood donations to identify severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)–reactive antibodies: December 2019–January 2020 SV Basavaraju, ME Patton, K Grimm, MAU Rasheed, S Lester, L Mills, ... Clinical Infectious Diseases 72 (12), e1004-e1009, 2021 | 142* | 2021 |
Identification of HIV gp41-specific antibodies that mediate killing of infected cells KL Williams, M Stumpf, NE Naiman, S Ding, M Garrett, T Gobillot, ... PLoS Pathogens 15 (2), e1007572, 2019 | 45 | 2019 |
Mapping SARS-CoV-2 Antibody Epitopes in COVID-19 Patients with a Multi-Coronavirus Protein Microarray D Camerini, AZ Randall, K Trappl-Kimmons, A Oberai, C Hung, J Edgar, ... Microbiology Spectrum 9 (2), e0141621, 2021 | 27 | 2021 |
SARS-CoV-2 infection relaxes peripheral B cell tolerance MJ Castleman, MM Stumpf, NR Therrien, MJ Smith, KE Lesteberg, ... Journal of Experimental Medicine 219 (6), e20212553, 2022 | 20 | 2022 |
Autoantibodies elicited with SARS-CoV-2 infection are linked to alterations in double negative B cells MJ Castleman, MM Stumpf, NR Therrien, MJ Smith, KE Lesteberg, ... Frontiers in immunology 13, 988125, 2022 | 17 | 2022 |
Infectious period of severe acute respiratory syndrome coronavirus 2 in 17 nursing home residents—Arkansas, June–August 2020 D Surie, JY Huang, AC Brown, P Gable, C Biedron, SE Gilbert, K Garner, ... Open Forum Infectious Diseases 8 (3), ofab048, 2021 | 16 | 2021 |
Development of antibody-dependent cell cytotoxicity function in HIV-1 antibodies LE Doepker, S Danon, E Harkins, D Ralph, Z Yaffe, A Dhar, C Wagner, ... eLife, 2021 | 10 | 2021 |
Descriptive evaluation of antibody responses to SARS-CoV-2 infection in plasma and gingival crevicular fluid in a nursing home cohort-Arkansas, June-August 2020 NE Brown, AK Lyons, AJ Schuh Infect Control Hosp Epidemiol 22, 1-24, 2021 | 4 | 2021 |
A Comparison of Less Invasive Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Diagnostic Specimens in Nursing Home Residents—Arkansas, June–August 2020 P Gable, JY Huang, SE Gilbert, S Bollinger, AK Lyons, S Sabour, D Surie, ... Clinical Infectious Diseases 73 (Issue Supplement_1), S58–S64, 2021 | 3 | 2021 |
Longitudinal serologic and viral testing post–SARS-CoV-2 infection and post-receipt of mRNA COVID-19 vaccine in a nursing home cohort—Georgia, October 2020‒April 2021 FA Tobolowsky, MA Waltenburg, ED Moritz, M Haile, JC DaSilva, ... Plos one 17 (10), e0275718, 2022 | 2 | 2022 |
Examination of SARS-CoV-2 serological test results from multiple commercial and laboratory platforms with an in-house serum panel SN Lester, M Stumpf, BD Freeman, L Mills, J Schiffer, V Semenova, T Jia, ... Access Microbiology 6 (2), 000463. v4, 2024 | 1 | 2024 |
Examination of common coronavirus antibodies in SARS-CoV-2-infected and uninfected participants in a household transmission investigation MM Stumpf, B Freeman, L Mills, S Lester, VT Chu, HL Kirking, ... Open Forum Infectious Diseases 9 (7), ofac212, 2022 | 1 | 2022 |
Descriptive evaluation of antibody responses to severe acute respiratory coronavirus virus 2 (SARS-CoV-2) infection in plasma and gingival crevicular fluid in a nursing home … NE Brown, AK Lyons, AJ Schuh, MM Stumpf, JL Harcourt, A Tamin, ... Infection Control & Hospital Epidemiology 43 (11), 1610-1617, 2022 | | 2022 |
Twelve-Month Follow-up of Early COVID-19 Cases in the United States: Cellular and Humoral Immune Longevity MM Shah, MAU Rasheed, JL Harcourt, GR Abedi, MM Stumpf, HL Kirking, ... Open Forum Infectious Diseases 9 (3), ofab664, 2022 | | 2022 |
Shedding of culturable virus, seroconversion, and 6-month follow-up antibody responses in the first 14 confirmed cases of COVID-19 in the United States ME Killerby, MAU Rasheed, A Tamin, J Harcourt, GR Abedi, X Lu, ... The Journal of Infectious Diseases, 2021 | | 2021 |